|
|
 |
|
GILD: Gilead Sciences Inc - Stock News |
Enter Ticker:
|
|
| Nov 24, 2009 |
Gilead Sciences to Present at the NASDAQ OMX 23rd Investor Program |
| Nov 24, 2009 |
Gilead, GSK Announce Viread Agreement In Asia (GILD,GSK) |
| Nov 24, 2009 |
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries |
| Nov 18, 2009 |
Fundamental and Technical Research for SFD, RHI, PFG, PDLI, GILD andFUQI Posted on BenchmarkJournal.com Today |
| Nov 17, 2009 |
Gilead Sciences to Present at the Lazard Capital Markets Annual Healthcare Conference |
| Nov 11, 2009 |
Gilead Sciences to Present at the Lazard Capital Markets 6TH Annual Healthcare Conference on Tuesday, November 17 |
| Nov 11, 2009 |
Graceway acquires rights to Gilead Sciences's investigational molecule |
| Nov 06, 2009 |
Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences |
| Nov 05, 2009 |
PicksThatMove.com Announces Investment Opinion on Dynergy Inc., Gilead Sciences Inc., Verenex Energy Inc., Empire Energy Corp Intl and Rentech Inc. |
| Nov 05, 2009 |
BiomedReports: News and FDA Updates for Genta (OTC:GETA), Gilead (Nasdaq:GILD), SurModics (Nasdaq:SRDX) |
| Nov 04, 2009 |
Gilead Sciences to Present at the 18th Annual Credit Suisse Healthcare Conference on Wednesday, November 11 |
| Nov 04, 2009 |
Trading Outlook for MannKind Corp. Issued by InvestorSoup.com |
| Nov 03, 2009 |
United States : Gilead Sciences to present Viread Phase III clinical trial data |
| Nov 03, 2009 |
BiomedReports: News and FDA Updates for Gilead (Nasdaq:GILD), Dendreon (Nasdaq:DNDN), Phase Forward (NASDAQ:PFWD) |
| Oct 31, 2009 |
Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread(R) For Chronic Hepatitis B |
| |
| ZACKS COMMENTARY FOR GILD |
| Nov 13, 2009 | Zacks Blog: Gilead Awaits Committee Outcome | | Nov 10, 2009 | Zacks Blog: Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics | | Nov 02, 2009 | Zacks Blog: United Therapeutics Misses | | Nov 02, 2009 | Zacks Blog: Gilead’s Positive Data | | Oct 22, 2009 | Zacks Equity Research: Report for GILD | | Oct 21, 2009 | Zacks Blog: Gilead’s Strong Performance | | Oct 14, 2009 | Zacks Blog: Zacks Bull and Bear of the Day Highlights: VimpelCom, Rite Aid Corporation, Johnson & Johnson, Elan Pharmaceuticals and Gilead Sciences, Inc. | | Oct 13, 2009 | Zacks Blog: J&J Beats & Raises Guidance | | Sep 18, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Merck, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and Abbott Labs | | Sep 17, 2009 | Zacks Blog: Approval for Merck’s Isentress | | Sep 17, 2009 | Zacks Blog: Zacks Industry Rank Analysis Highlights: D.R. Horton, KB Home, Pulte Homes, Allstate, Hartford Financial Services, Travelers, Loews, Humana, Stericycle, C.R.... | | Sep 16, 2009 | Zacks Industry Rank Analysis: Third-Quarter Earnings Forecast |
|
|
Sponsored Links 
0.05